Drug Trial Radar · NCT06724237
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
294
Planned (sponsor's estimate)
Start
Jun 18, 2025
Primary completion
Apr 30, 2074
Study completion Apr 30, 2075
Sponsor
- Lead sponsor
- Eastern Cooperative Oncology GroupResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Dec 9, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with peripheral T-cell lymphoma who achieved a complete response after initial chemotherapy. Usual treatment after a complete response may include observation or high dose chemotherapy followed by an autologous stem cell transplant, however, it is not known if a transplant if beneficial. Giving chemotherapy before a stem cell transplant helps kill cancer cells in the body and helps make room in the patient's bone marrow for new blood-forming cells (stem cells) to grow. Stem cells removed prior to treatment are then returned to the patient to replace the blood forming cells that were destroyed by the chemotherapy. Giving high dose chemotherapy followed by an autologous stem cell transplant may be more effective compared to observation only in treating patients with peripheral T-cell lymphoma who have achieved a complete response after initial chemotherapy.
Conditions
- Anaplastic Large Cell Lymphoma, ALK-Negative
- Follicular Helper T-Cell Lymphoma
- Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type
- Peripheral T-Cell Lymphoma, Not Otherwise Specified
Interventions
Autologous Hematopoietic Stem Cell TransplantationProcedure
Undergo ASCT
Best PracticeOther
Receive standard of care observation
Biospecimen CollectionProcedure
Undergo blood sample collection
Bone Marrow AspirationProcedure
Undergo bone marrow aspiration and biopsy
Bone Marrow BiopsyProcedure
Undergo bone marrow aspiration and biopsy
Computed TomographyProcedure
Undergo CT or PET/CT
High Dose ChemotherapyDrug
Receive high dose chemotherapy
LeukapheresisProcedure
Undergo leukapheresis
Positron Emission TomographyProcedure
Undergo PET/CT
Stem Cell Mobilization TherapyDrug
Receive stem cell mobilization therapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free survival (PFS)Time frame: From study randomization to documented disease progression or death, whichever occurs first, assessed up to 12 years
Locations
165 sites in 2 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama · Not yet recruiting
Anchorage Associates in Radiation Medicine
Anchorage, Alaska · Recruiting
Alaska Breast Care and Surgery LLC
Anchorage, Alaska · Recruiting
Alaska Oncology and Hematology LLC
Anchorage, Alaska · Recruiting
Alaska Women's Cancer Care
Anchorage, Alaska · Recruiting
Katmai Oncology Group
Anchorage, Alaska · Recruiting
Providence Alaska Medical Center
Anchorage, Alaska · Recruiting
Fairbanks Memorial Hospital
Fairbanks, Alaska · Active not recruiting
Mayo Clinic Hospital in Arizona
Phoenix, Arizona · Recruiting
Banner University Medical Center - Tucson
Tucson, Arizona · Recruiting
University of Arizona Cancer Center-North Campus
Tucson, Arizona · Recruiting
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Burbank, California · Recruiting
City of Hope Comprehensive Cancer Center
Duarte, California · Recruiting
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California · Recruiting
Contra Costa Regional Medical Center
Martinez, California · Active not recruiting
Providence Queen of The Valley
Napa, California · Recruiting
UC Irvine Health/Chao Family Comprehensive Cancer Center
Orange, California · Recruiting
Providence Medical Foundation - Santa Rosa
Santa Rosa, California · Recruiting
Providence Santa Rosa Memorial Hospital
Santa Rosa, California · Recruiting
BASS Medical Group - Lennon
Walnut Creek, California · Active not recruiting
Rocky Mountain Cancer Centers-Aurora
Aurora, Colorado · Active not recruiting
Boulder Community Foothills Hospital
Boulder, Colorado · Active not recruiting
Rocky Mountain Cancer Centers-Boulder
Boulder, Colorado · Active not recruiting
Rocky Mountain Cancer Centers - Centennial
Centennial, Colorado · Active not recruiting
The Women's Imaging Center
Denver, Colorado · Active not recruiting
Colorado Blood Cancer Institute
Denver, Colorado · Active not recruiting
Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado · Active not recruiting
Rocky Mountain Cancer Centers-Midtown
Denver, Colorado · Active not recruiting
Rocky Mountain Cancer Centers-Rose
Denver, Colorado · Active not recruiting
Rocky Mountain Cancer Centers - Swedish
Englewood, Colorado · Active not recruiting
The Melanoma and Skin Cancer Institute
Englewood, Colorado · Active not recruiting
Rocky Mountain Cancer Centers-Lakewood
Lakewood, Colorado · Active not recruiting
Rocky Mountain Cancer Centers-Littleton
Littleton, Colorado · Active not recruiting
Rocky Mountain Cancer Centers-Sky Ridge
Lone Tree, Colorado · Active not recruiting
Rocky Mountain Cancer Centers-Longmont
Longmont, Colorado · Active not recruiting
Rocky Mountain Cancer Centers-Thornton
Thornton, Colorado · Active not recruiting
Beebe Medical Center
Lewes, Delaware · Recruiting
Beebe South Coastal Health Campus
Millville, Delaware · Recruiting
Helen F Graham Cancer Center
Newark, Delaware · Recruiting
Medical Oncology Hematology Consultants PA
Newark, Delaware · Recruiting
Showing 40 of 165 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.